AstraZeneca PLC (NYSE:AZN) falls under the large cap category with a market cap of 87.39 B. The following data highlights AstraZeneca PLC (AZN) for Monday June 19, 2017 showing the earning date of 7/27/2017 8:30:00 AM.
AstraZeneca PLC (NYSE:AZN), a Drug Manufacturers – Major company from Healthcare sector has been doing very well. The company has reported a price of $34.54 today, marking a change of 1.26%.
AstraZeneca PLC has a current return on equity (ROE) of 24.90% while its debt to equity stands at 1.34. The return on investment (ROI) is at 15.00% and the gross margin is reported to be 82.70%.
AstraZeneca PLC is predicting a healthy earnings per share growth of -17.60% over the period of next five years.
The stats for AstraZeneca PLC’s performance is below.
The weekly performance stands at 1.08%, while the monthly performance measure stands at 1.08%. Not surprisingly its volatility is at 0.99% with an average volume of 4109.4. Volatility is a statistical measure of the dispersion of returns for a given security. It can be measured by using the variance between returns from the market index. Generally speaking, there is always a positive correlation between high volatility and high risk.
The performance per month is at 1.08%, while the performance per quarter stands at .
has a float short of 1.11% at present and the short ratio is at 6.77. Shares shorted can actually exceed 50% of the float in a company. Because the float is the amount of a company’s shares that are publicly owned, all tradable shares can therefore be borrowed by short sellers.
The numbers in regards to AstraZeneca PLC’s valuation are below.
The market cap is at 87.39 B, while the P/E stands at 25.8, with a P/S of 3.92 and earnings per share this year of 23.80%.
The earnings per share is used as a primary indicator of a company’s profitability or loss. Earnings per share is basically the portion of a company’s profit that is allocated to each outstanding share of common stock.
Candle Graph for (NYSE: AZN)
AstraZeneca PLC NYSE : AZN | Healthcare | Drug Manufacturers – Major
Disclaimer: The views, opinions, and information expressed in this article are those of the authors and will not necessarily reflect the official policy or position of any company stakeholders, financial professionals, or analysts.. Examples of analysis performed within this article are for demonstration purposes only. They should not be utilized to make stock portfolio or financial decisions as they are based on limited and open source information only. Hence the assumptions made within the analysis are not reflective of the position of any analysts or financial professionals.